Roche Holding Company Profile (VTX:ROG)

About Roche Holding

Roche Holding logoRoche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai. Its Diagnostics division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. It develops medicines for the disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its product portfolio consists of Pharmaceuticals, Solutions for Diagnostics and Products for Researchers. Its Pharmaceutical products include ACTEMRA and CellCept. Its Solutions for Diagnostics products include Accu-Chek Active System and Accu-Chek Aviva Nano System. The Company's Products for Researchers include Cedex HiRes and Genome Sequencer FLX System.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: VTX
  • Symbol: ROG
  • CUSIP:
Key Metrics:
  • Previous Close: $89.89
  • 50 Day Moving Average: $80.45
  • 200 Day Moving Average: $68.13
  • Trailing P/E Ratio: 32.25
  • P/E Growth: 1.38
  • Market Cap: $1.54B
Additional Links:
Companies Related to Roche Holding:

Analyst Ratings

Consensus Ratings for Roche Holding (VTX:ROG) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Roche Holding (VTX:ROG)
Show:
DateFirmActionRatingPrice TargetDetails
2/2/2017J P Morgan Chase & CoReiterated RatingBuyView Rating Details
11/3/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
7/19/2016Goldman Sachs Group, Inc. (The)Reiterated RatingBuyView Rating Details
11/13/2015Morgan StanleyReiterated RatingBuyView Rating Details
(Data available from 2/24/2015 forward)

Earnings

Earnings History for Roche Holding (VTX:ROG)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Roche Holding (VTX:ROG)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Roche Holding (VTX:ROG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Roche Holding (VTX:ROG)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Roche Holding (VTX:ROG)
DateHeadline
nasdaq.com logoNovartis cancer drug Zykadia gets FDA priority review - Nasdaq (VTX:ROG)
www.nasdaq.com - February 23 at 8:20 AM
capitalcube.com logoRogers Corp. :ROG-US: Earnings Analysis: 2016 By the Numbers : February 22, 2017 (VTX:ROG)
www.capitalcube.com - February 22 at 7:46 PM
finance.yahoo.com logoEdited Transcript of ROG earnings conference call or presentation 21-Feb-17 2:00pm GMT (VTX:ROG)
finance.yahoo.com - February 22 at 9:39 AM
capitalcube.com logoRogers Corp. breached its 50 day moving average in a Bullish Manner : ROG-US : February 22, 2017 (VTX:ROG)
www.capitalcube.com - February 22 at 9:39 AM
finance.yahoo.com logoRogers (ROG) Shows Strength: Stock Adds 9.8% in Session (VTX:ROG)
finance.yahoo.com - February 22 at 9:39 AM
4-traders.com logoRoche : receives EU approval of Alecensa (alectinib) for people with previously treated ALK-positive non-small cell lung cancer (VTX:ROG)
www.4-traders.com - February 21 at 5:16 PM
finance.yahoo.com logoRogers Corporation Reports Fourth Quarter 2016 and Full Year Results (VTX:ROG)
finance.yahoo.com - February 20 at 6:47 PM
finance.yahoo.com logoRogers Schedules Q4 & Full Year 2016 Earnings Call for Feb 21 (VTX:ROG)
finance.yahoo.com - February 10 at 11:05 PM
nasdaq.com logoRoche said to consider options for Diabetes unit- Bloomberg - Nasdaq (VTX:ROG)
www.nasdaq.com - February 1 at 3:44 AM
reuters.com logoBristol-Myers cuts 2017 outlook amid Opdivo competition - Reuters (VTX:ROG)
www.reuters.com - January 27 at 2:24 AM
nasdaq.com logoEurope's oncologists back biosimilar versions of cancer drugs ... - Nasdaq (VTX:ROG)
www.nasdaq.com - January 18 at 8:13 PM
finance.yahoo.com logoTweedy Browne Global Value Buys , , , Sells Hasbro Inc, , - Yahoo Finance (VTX:ROG)
finance.yahoo.com - January 10 at 10:10 PM
News IconExclusive: J&J discussing breaking up Actelion in an acquisition - sources - TODAYonline (VTX:ROG)
www.todayonline.com - December 29 at 7:34 PM
News IconRoche's emicizumab haemophilia drug succeeds in trial - Yahoo News UK (VTX:ROG)
uk.news.yahoo.com - December 23 at 8:03 AM
investing.com logoRoche's emicizumab haemophilia drug succeeds in trial - Investing.com UK (VTX:ROG)
uk.investing.com - December 22 at 7:55 PM
4-traders.com logoRoche : emicizumab for haemophilia A meets primary endpoint in phase III study (VTX:ROG)
www.4-traders.com - December 22 at 2:08 AM
4-traders.com logoRoche : Positive Phase III results for Roche’s investigational medicine OCREVUS® (ocrelizumab) published in New England Journal of Medicine (VTX:ROG)
www.4-traders.com - December 21 at 9:07 PM
finance.yahoo.com logoBallard Power (BLDP) Looks Good: Stock Moves 9.5% Higher (VTX:ROG)
finance.yahoo.com - December 20 at 2:20 PM
News IconRaiffeisen to issue structured products with SIX Swiss Exchange - LeapRate (VTX:ROG)
www.leaprate.com - December 8 at 8:45 AM
reuters.com logoEx-InterMune executive, friend found liable for insider trading | Reuters - Reuters UK (VTX:ROG)
uk.reuters.com - November 15 at 7:47 PM
4-traders.com logoRoche : launches imCORE, a global network of cancer immunotherapy centers of excellence (VTX:ROG)
www.4-traders.com - November 15 at 10:53 AM
News IconBlueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as Chief Scientific Officer and the Transition of Christoph... (VTX:ROG)
ih.advfn.com - November 14 at 7:32 PM
finance.yahoo.com logoBlueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as Chief Scientific Officer and the … (VTX:ROG)
finance.yahoo.com - November 14 at 7:32 PM
seekingalpha.com logoRoche's Actemra successful in late-stage study in giant cell arteritis (VTX:ROG)
seekingalpha.com - November 14 at 7:32 PM
reuters.com logoRegeneron profit tops Street on lower costs - Reuters (VTX:ROG)
www.reuters.com - November 4 at 6:46 PM
News IconForget The Noise, Here's Where The Value Lies In Growblox Sciences Inc (OTCMKTS:GBLX) - Insider Financial (VTX:ROG)
www.insiderfinancial.com - November 4 at 10:57 AM
biz.yahoo.com logoROGERS CORP Files SEC form 10-Q, Quarterly Report (VTX:ROG)
biz.yahoo.com - November 3 at 11:29 AM
sg.finance.yahoo.com logoRogers Corp. posts 3Q profit (VTX:ROG)
sg.finance.yahoo.com - November 2 at 7:32 PM
finance.yahoo.com logo4:58 pm Rogers Corp beats by $0.13, beats on revs; guides Q4 EPS in-line (VTX:ROG)
finance.yahoo.com - November 2 at 7:32 PM
biz.yahoo.com logoQ3 2016 Rogers Corp Earnings Release - After Market Close (VTX:ROG)
biz.yahoo.com - November 2 at 10:44 AM
publicnow.com logoRogers Corporation Invites You to Join its 2016 Third Quarter Earnings Conference Call (VTX:ROG)
www.publicnow.com - October 26 at 7:07 PM
4-traders.com logoRoche : FDA approves Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for people with a specific type of metastatic lung cancer (VTX:ROG)
www.4-traders.com - October 20 at 7:22 PM
investing.com logoRoche's Tecentriq Wins FDA Nod For Additional Indication - Investing.com (VTX:ROG)
www.investing.com - October 19 at 3:41 PM
4-traders.com logoRoche : FDA grants breakthrough therapy designation for Roche's Actemra/RoActemra in giant cell arteritis, a form of vasculitis (VTX:ROG)
www.4-traders.com - October 10 at 11:50 AM
capitalcube.com logoRogers Corp. breached its 50 day moving average in a Bullish Manner : ROG-US : September 23, 2016 (VTX:ROG)
www.capitalcube.com - September 23 at 11:47 AM
News IconMorgan Stanley Reaffirms “Buy” Rating for Roche Holding (ROG) - Petro Global News 24 (VTX:ROG)
petroglobalnews24.com - September 22 at 11:53 AM
finance.yahoo.com logoCoverage initiated on Rogers Corp by Needham (VTX:ROG)
finance.yahoo.com - September 13 at 11:57 AM
capitalcube.com logoETF’s with exposure to Rogers Corp. : September 6, 2016 (VTX:ROG)
www.capitalcube.com - September 6 at 11:51 AM
investing.com logoEuropean stocks rise on Chinese data, financials lead; DAX up 0.32% - Investing.com (VTX:ROG)
www.investing.com - September 1 at 10:15 AM
finance.yahoo.com logoRogers Corporation to Participate in Drexel Hamilton Telecom, Media & Technology Conference (VTX:ROG)
finance.yahoo.com - August 31 at 12:21 PM
marketwatch.com logoFDA grants Roche Zika test emergency authorization - MarketWatch (VTX:ROG)
www.marketwatch.com - August 30 at 10:24 AM
capitalcube.com logoETF’s with exposure to Rogers Corp. : August 24, 2016 (VTX:ROG)
www.capitalcube.com - August 24 at 6:53 PM
News IconPfizer Inc.: Medivation Acquisition Could Send Pfizer Stock Soaring - Profit Confidential (VTX:ROG)
www.profitconfidential.com - August 23 at 11:41 AM
finance.yahoo.com logoROGERS CORP Financials (VTX:ROG)
finance.yahoo.com - August 17 at 7:31 PM
capitalcube.com logoRogers Corp. :ROG-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (VTX:ROG)
www.capitalcube.com - August 12 at 7:17 PM
capitalcube.com logoETF’s with exposure to Rogers Corp. : August 11, 2016 (VTX:ROG)
www.capitalcube.com - August 11 at 7:41 PM
News IconSamsung Biologics likely to seek IPO approval (VTX:ROG)
www.legalbusinessonline.com - August 10 at 7:40 PM
thestreet.com logoNot-So-Jolly Rogers Thanks to Quant Downgrade, Bearish Chart (VTX:ROG)
realmoney.thestreet.com - August 10 at 7:40 PM
marketwatch.com logoSamsung BioLogics seeks to raise up to $2.5 billion from IPO - MarketWatch (VTX:ROG)
www.marketwatch.com - August 10 at 10:18 AM
reuters.com logoSamsung Biologics likely to seek IPO approval this week-bourse officials (VTX:ROG)
www.reuters.com - August 9 at 10:24 AM

Social

What is Roche Holding's stock symbol?

Roche Holding trades on the VTX under the ticker symbol "ROG."


Last Updated on 2/24/2017 by MarketBeat.com Staff